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Abstract
Ubiquitination is a process that marks proteins for various cell-signaling pathways, namely protein degradation and
other processes. These pathways are essential in a wide array of cellular processes, including defense mechanisms
against invading pathogens. The ubiquitination process is universally found in all eukaryotic organisms, including
plants and animals, and thus plays a vital role in cellular homeostasis. Recently, more discoveries have been made on
prokaryotic effector proteins that hijack the ubiquitination system even when they do not possess a ubiquitin system of
their own. MavC, also known as lpg2147 (Gan, Nakayasu, Hollenbeck, & Luo, 2019; Puvar et al., 2020; Valleau et al.,
2018), has been found to be a ubiquitinating enzyme that ubiquitinates UbE2N by bypassing the usual E1, E2, E3
ubiquitination pathway. MavC plays an important role in the infection of Legionella pneumophila, which is the culprit
of Legionnaires’ disease. Through earlier molecular biology analysis, it has been discovered that a neighboring gene on
the same locus as MavC encodes lpg2149, which has been characterized to inhibit MavC’s function. Given the novelty
of this protein, this research project aims to achieve cloning, expression, and purification of lpg2149 so that in its
inhibitory complex lpg2149 can be captured by X-ray crystallography. An attempt was made to crystallize and obtain
the structure of lpg2149 with MavC. With the optimization of lpg2149 production demonstrated in this project, a
better understanding of L. pneumophila pathogenesis can be obtained, which would help in our understanding of
regulating L. pneumophila infection.
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INTRODUCTION
Ubiquitination is a posttranslational modification that
plays a role in many processes in eukaryotic cells,
including protein degradation, protein trafficking,
protein localization, and protein regulation. During
ubiquitination, proteins are modified with the addition
of a single ubiquitin or ubiquitin protein chains. The
conformation and number of ubiquitin attached to the
protein act as a code that determines that protein’s fate in
the cell, one example being protein degradation. Three
enzymes known as the E1, E2, and E3 enzymes take part
in ubiquitination. E1s are ubiquitin-activating enzymes
that catalyze the first step of ubiquitination, wherein
adenosine triphosphate is used to generate an active
ubiquitin that is primed for conjugation with E2. E2s are
ubiquitin-conjugating enzymes that transfer ubiquitin to
their partner E3s. Finally, E3s are ubiquitin-ligating
enzymes that give specificity to the substrate proteins.
More ubiquitin molecules can then be subsequently
added to the initial ubiquitin, forming a polyubiquitin
chain on the substrate protein. The conformation and
number of ubiquitin attached to the substrate protein
ultimately affect what happens to the protein. In humans,
there are 2 E1s, 40 E2s, and more than 600 E3s
(Komander & Rape, 2012). To replenish the cellular
ubiquitin pool and to remove cellular response signals
that arise from polyubiquitination, there are enzymes
that can cleave the isopeptide bond formed between a
specific protein and ubiquitin so the ubiquitin can be
reused. These enzymes are deubiquitinating enzymes,
and they essentially reverse ubiquitination (Clague,
Urbé, & Komander, 2019).
Bacteria are prokaryotic organisms that do not possess the
ubiquitination system of their own. However, many of
these pathogens have evolved to secrete effector proteins
that affect cellular pathways, like ubiquitination, in the
host cells it invades. Effector proteins are biological
molecules that act to hijack or inhibit host proteins, which
in turn changes and regulates the function of that particular host protein. Legionella pneumophila is one of the
bacteria that expresses effectors that target ubiquitination
pathways in the host cell. Among the 330 effector proteins
secreted by L. pneumophila is MavC, also known as
lpg2147 (Puvar et al., 2020; Valleau et al., 2018). MavC
aids in deactivating NF-κB, a major immune regulatory
protein. When MavC is not present, the

ubiquitin-conjugating E2 enzyme UbE2N aids in activating a protein (NEMO) required to phosphorylate IκBα. In
this phosphorylated state, IκBα dissociates from NF-κB, so
NF-κB is activated (Sato, Yoshikawa, Yamashita, Yamagata,
& Fukai, 2009). When MavC is active it adds ubiquitin to
UbE2N, thus deactivating UbE2N, which leads to the
downstream effect of no phosphorylation on IκBα (Gan et
al., 2019; Valleau et al., 2018). IκBα remains attached to
NF-κB, which prevents the immune response from
kicking in, indicating that L. pneumophila inhibits NF-κB
to suppress and bypass the host immune response.
Interestingly, MavC is regulated by another L. pneumophila effector known as lpg2149. Lpg2149 acts as an
inhibitor to MavC and also inhibits another protein,
MvcA (lpg2148), which has a homologous structure to
MavC. MvcA is a ubiquitin specific deamidase that
targets ubiquitinated UbE2N (UbE2N-Ub), the reaction
product of MavC (Valleau et al., 2018). These three
effectors of L. pneumophila play an important role in the
regulation of UbE2N during L. pneumophila infection.
UbE2N plays a role in other cellular pathways outside of
the NF-κB pathway, such as its importance in mitosis
and p53 regulation. These other pathways related to
UbE2N are necessary for the intracellular replication of
L. pneumophila. Additionally, even though L. pneumophila needs to inactivate NF-κB to bypass the host immune
response, prolonged deactivation of the NF-κB pathway
negatively affects L. pneumophila intracellular replication. As a result, the bacteria need to be able to regulate
ubiquitination of UbE2N in order to reproduce in the
host as well as avoid the host immune response. Lpg2149
is an interesting target for further study due to its
important role in enzyme regulation of UbE2N manipulators. Lpg2149 optimization is important for future
studies that aim to better understand lpg2149 and L.
pneumophila pathogenesis. In this project, a protocol to
produce lpg2149 has been optimized so that crystallization studies with its binding partners can be performed
and for further studies of lpg2149 inhibition activity.

METHODS AND RESULTS
To produce the protein on a large scale, a recombinant
protein production method was employed. First, the
lpg2149 gene from L. pneumophila was cloned into an
expression vector, followed by transformation into an

Escherichia coli strain for protein expression. Protein
expression was proceeded by affinity chromatography
using the recombinantly introduced tag on the protein.

Site-Directed Mutagenesis and Cloning
Cloning a gene into a vector requires amplification by a
process called polymerase chain reaction (PCR), which
can be broken down into three steps: denaturation,
annealing, and extension. Denaturation occurs at 95°C, a
temperature that is high enough to break the hydrogen
bonds between deoxyribonucleic acid (DNA) strands so
they can separate. The temperature is then reduced to a
value that is approximately 5°C lower than the theoretical melting point of the primers. This is the optimal
temperature at which the primers anneal to the template
DNA as the temperature is low enough so that the
primers do not denature from the template DNA but
high enough that they only bind to their specific complementary sequences. Generally, the temperature for
annealing is around 45–65°C. The next step of PCR is
extension, which occurs at 72°C. This is the optimal
temperature at which the Taq polymerase enzyme
functions. During extension, the polymerase enzyme
extends the primer sequence by adding nucleotide bases
to the 3′ end. PCR is conducted in a thermocycler that
cycles through the different temperature settings of each
step so that the three main steps of PCR can repeat. The
thermocycler typically runs about 25–35 cycles, leading
to the synthesis of millions of copies of the original DNA
template (Figure 1a). Before conducting PCR, primers
were designed to insert the lpg2149 gene into the
expression vector pGEX-6p-1. These primers were
designed with overhangs that insert into the multiple
cloning site of the expression vector, hence forming the
plasmid with our lpg2149 insert (Sarkar & Sommer,
1990). Using a program called SnapGene, a primer was
designed to specifically anneal to a particular DNA
sequence. After the primers were designed and synthesized, PCR was conducted to amplify the plasmid with
the lpg2149 gene insert. Alternatively, PCR could also be
used to perform site-directed mutagenesis to specifically
mutate residues of interest for activity studies. With the
primer, the codon of the desired mutation would be
inserted in place of the wild-type amino acid codon, and
the extension time would span the time it takes to
elongate to the full length of the vector with insert.
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FIGURE 1. The process of cloning a gene into an expression vector uses various techniques including (a) PCR, (b–d) DH5α
bacteria transformation and cultures, (e) DNA plasmid extraction, and (f) DNA sequencing.

After PCR, DpnI enzyme was added to the reaction to cut
up the parental template DNA that does not contain the
desired gene. The parental DNA is methylated so the DpnI
enzyme can digest parental DNA strands upon recognition
of methylation patterns. This ensured that only the desired
plasmid (with insert for cloning or with mutation for
mutagenesis) was present. After DpnI digestion, the
plasmids were transformed into DH5α bacteria. DH5α is a
specific strain of E. coli that does not contain endA or recA
genes. EndA encodes an enzyme, Endonuclease A, that
digests DNA that is not a part of the bacteria. RecA encodes
RecA, an enzyme involved in DNA recombination. The
lack of these two enzymes allowed the plasmid to be
reproduced without being cut up by the endonuclease A or
recombined with the bacterial DNA by the RecA enzyme.
Transformation involves a process of incubating, heating,
and cooling to enable the E. coli to take up the plasmid.
First, the mutant plasmids were incubated with DH5α cells
so that the plasmids could equally distribute around the E.
coli (see Figure 1b). Once the plasmids had been incubated
with the E. coli, the bacteria were subjected to heat shock
by being placed in a water bath set at 42°C. The heat
opened transient pores in the cell membrane of the E. coli,
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allowing the plasmids to enter the cell. The transformation
mix was then cooled on ice for a few minutes to allow the
pores to close before being incubated for an hour in
Lysogeny broth (LB) media without antibiotics at 37°C.
This period of outgrowth allowed the cells transformed
with the plasmid to replicate. After the hour-long incubation, cells were plated on an LB agar plate supplemented
with the antibiotic corresponding to the selectable antibiotic resistance gene in the plasmid (see Figure 1c), which
allowed only the bacterial cells transformed with the
plasmid to survive. The plate was then placed in a 37°C
incubator overnight so the bacteria could grow and form
colonies. The next day one of the colonies was transferred
to a tube containing 10mL of LB media to set up an
overnight culture (see Figure 1d). The 10 mL overnight
culture was incubated at 37°C, and after about 16 hours the
cells were pelleted for plasmid DNA extraction using a
commercially available miniprep kit (see Figure 1e).
DNA extraction began by pelleting the bacteria and
removing the LB media before resuspending it in the P1
buffer, which contains 50 mM Tris-Cl at pH 8.0, 10 mM
ethylenediaminetetraacetic acid and 100 µg/ml of ribonuclease A. Each of these components played an important

role in DNA extraction. The Tris-Cl buffer helps to
maintain a constant pH of around 8. Ethylenediamine
tetraacetic acid chelates the metal ions, which decrease the
activity of enzymes with metal ion cofactors such as
deoxyribonuclease. As a result, this protected the plasmid
DNA from being degraded by deoxyribonuclease. The
ribonuclease A in the P1 buffer (Qiagen) helps to remove
ribonucleic acid from the plasmid preparation by cutting
up and degrading the bacterial ribonucleic acid. After the
cells had been resuspended in 250 µL of P1 buffer, 250 µL
of P2 buffer was added to lyse the cells, and the lysis
reaction was incubated at room temperature for 5 minutes. P2 contains 1% sodium dodecyl sulfate (SDS) and
200 mM NaOH. SDS is a detergent that punctures cell and
nuclear membranes while also solubilizing the proteins
and lipids that make up the membranes. The NaOH in the
lysis buffer caused osmotic damage to the bacterial cell
walls so that the plasmid DNA could leave the cell and
come into the solution. After the lysis reaction, 350 µL of
N3 buffer was added to neutralize the reaction. N3 buffer
neutralizes the NaOH and SDS, allowing the cell debris,
chromosomal DNA, and bacteria proteins to precipitate
out. Additionally, N3 buffer has guanidine HCl to denature soluble proteins. After the reaction was neutralized,
the sample was centrifuged for 10 minutes so that the cell
debris, chromosomal DNA, and proteins were spun down
into a pellet. The supernatant was then transferred to a

spin column. It was centrifuged for 1 minute, and the
flow-through was discarded. The column was then washed
with 750 µL of PE buffer, which contains ethanol and
removes excess salt from the column. The column was
centrifuged for 1 minute. The flow-through was then
discarded, and the column was centrifuged for an additional minute to remove any leftover wash buffer. The spin
column was then placed into a clean 1.5 mL microcentrifuge tube, and 50 μl of EB buffer (10 mM Tris-Cl, pH 8.5)
was added to elute the DNA. The solution sat on the
membrane for 1 minute and then was centrifuged for
1 minute. The spin column was then discarded, and the
plasmid DNA was collected in the microcentrifuge tube.
The extracted DNA could then be sequenced to ensure
that it had the correct sequence (see Figure 1f).

Protein Expression
After the desired gene had been cloned into the vector of
choice and the sequence was verified, the resultant
plasmid needed to be introduced into BL21(DE3)
bacteria so that the protein of interest could be recombinantly expressed. BL21(DE3) is an optimized E. coli
strain for protein expression. The process of BL21(DE3)
transformation mirrored the DH5α transformation
(Figures 2a and 2b).

FIGURE 2. Protein expression flowchart. The plasmid DNA is transformed into BL21(DE3) bacteria, and a bacterial culture
is produced (a–d). IPTG is added to induce protein expression of the gene of interest (e). Then the cells are harvested by
centrifuging them and removing the liquid LB media (f).
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After colonies were grown on the plate, one of the
colonies was transferred into a tube containing 10mL of
liquid LB media to set up an overnight culture (see
Figure 2c). After the bacteria had been incubated in the
LB media overnight, the 10 mL overnight culture was
added to a 1L flask of LB media (see Figure 2d). This was
inoculated for 2–3 hours, and then 350μL of 1M
Isopropyl β-D-1-thiogalactopyranoside (IPTG, final
concentration of 350μM) was added to the culture. IPTG
was the reagent used to induce protein expression of the
gene under the control of the lac operon. When IPTG
was added, protein expression was induced because the
lac repressor protein binds to the IPTG and dissociates
from the lac operon. The incubation temperature was
adjusted based on the protein being expressed. For this
project, protein expression was induced at 18°C for 16 to
18 hours (see Figure 2e). After protein expression, the
cells were harvested by centrifuging for 6 minutes at
3,000 rpm. Centrifuging the cultures caused the cells to
spin down and collect as a pellet. The remaining liquid
LB media was then removed so that all that remained
were the pelleted cells (see Figure 2f).
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(Figure 3d). There are different types of protein tags, and
the process for purifying proteins differs slightly depending on which tag was incorporated in the protein of
interest. This project used a pGEX-6p-1 plasmid, which
incorporates a glutathione-S-transferase (GST) tag onto
the N-terminus of lpg2149. GST tags bind to beads with
chains of glutathione immobilized on the bead. The
glutathione binds with the GST incorporated into the
protein of interest with high selectivity and high affinity
so that the protein of interest will remain in the column.

Protein Purification

After the supernatant from the ultracentrifuge was
equilibrated and passed through the column, the column
was washed twice (each with a volume of 5 times the
bead volume) with 1X PBS buffer to remove the proteins
the bacteria had produced for normal cellular function
(see Figure 3e). After the washes, an elution buffer was
added to allow the protein of interest to flow through the
column (see Figure 3f). For GST, free reduced glutathione was used to elute, as the free glutathione would bind
to the GST. This allowed the protein with GST that was
bound to free glutathione to flow through the column.
After elution, PreScission protease was then added to the
eluate to cleave the GST tag off from the protein of
interest. The solution was then placed in a dialysis bag.

Once the bacterial cells were harvested by centrifugation,
the proteins needed to be isolated from the cells. The
harvested cells were resuspended in 1X PBS buffer. After
the cells were resuspended, lysozyme was added.
Lysozyme catalyzed the breaking down of the cell walls of
bacteria (Figure 3a). After the lysozyme was added and
incubated for 30 minutes, the cells were lysed using a
French press. The French press applied high pressure to
the cells, which caused the cells to break open (Figure 3b).
After two passes through the French press, the solution
was ultracentrifuged for an hour so that the cell debris,
such as membranes, would spin to the bottom, allowing
the supernatant, which contained the soluble proteins, to
be collected (Figure 3c). The supernatant was then loaded
into a protein purification column, and after allowing the
proteins to equilibrate or bind to the beads, it was passed
through the column. The protein purification column
contained beads that bind to a specific tag that was
incorporated into the protein of interest through the
recombinant plasmid. The binding of the tag to the beads
allowed all the other unwanted proteins to flow through
while the protein of interest remained in the column

Once the sample had been transferred to the dialysis
bag, the dialysis bag was then placed in a buffer that
contains 0.4 M KCl in 1X PBS. In addition, dithiothreitol could also be added to the dialysis buffer.
Dithiothreitol is a reducing agent that prevents nonspecific disulfide bonds from forming. As mentioned
previously, during dialysis the GST tags that were
previously attached to the protein of interest were
proteolytically removed due to the action of the
PreScission protease (Figure see 3g). However, the
purpose of the dialysis was really to remove free
glutathione from the GST tag so that subtraction could
occur. Once dialysis had finished, the solution was run
through the GST bead column again. The beads bind to
the protein tag once more only if the free glutathione
has been removed from the sample. Because the GST
could again bind to the GST beads, the protein of
interest would flow through, as it was no longer
attached to the tag (see Figure 3h). The subtracted
solution, which contained only the protein of interest,
was then concentrated. Samples taken at various points
during the process were run on gel electrophoresis to
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FIGURE 3. Protein purification flowchart. Protein purification begins with cell lysis and the isolation of proteins from other
cellular components (a–c). Affinity column purification is then conducted to isolate the protein of interest (red) from the
undesired proteins (brown) (d–i). This occurs due to the tag (blue) binding affinity with the porous beads (black) and the
elution buffer (green).

analyze the affinity column purification (see Figure 3i).
Size exclusion chromatography was then run to obtain
a completely pure sample of the protein by further
separating the desired protein and potential contaminants based on size. Size exclusion separates proteins by
size, wherein smaller proteins elute at a longer retention
time due to the path they have to take through the size
exclusion beads (Figure 4). After the proteins of interest
are obtained and purified, the proteins could be
analyzed by activity assays or used for structural studies.

Crystallization and X-Ray Crystallography
A high concentration of the desired proteins was
prepared following the previously described protocol
and then added to different conditions from several
commercially available crystal screening sets in hopes of
growing a crystal. In each well of the set there are
different condition buffers that lead to different vapor
diffusion conditions, some more optimum for different
protein crystals to grow in. The protein solution is then
mixed with a small portion of the crystal screen buffer to
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FIGURE 4. Protein purification gel. The affinity column purification gel lanes contain the protein ladder, the supernatant
after French press lysis (load), the first flow-through, the wash, the eluate, the postdialysis, the subtracted sample, and
the concentrated sample, respectively (a). Size exclusion is conducted, and a gel is run with fractions that appear only to
contain the protein of interest (b).

form a drop on a cover slip. The cover slip is then
inverted over the well and sealed. The concentration in
the drop equilibrates with the concentration via vapor
diffusion, hopefully allowing a crystal to form (Figure
5a). When the proteins in the drop packs favorably, a
crystal is formed. This crystal can then be looped and
diffracted by X-ray diffraction (Figures 5b–d). In this
process an X-ray beam is directed to the crystal, and by
rotating the crystal, a complete sphere of data can be
obtained. As the crystal is rotated, the beam will be
diffracted at different angles, thus forming a set of
diffraction patterns. The set of diffraction patterns can be
correlated to the distribution of electrons of individual
atoms that make up the protein or protein complexes in
the crystal. The diffraction pattern set is analyzed using
computer software, such as Phenix and CCP4, to give an
outline of the electron density map (Figure 5e). The
structure can then be solved by molecular replacement if
a model is available or by stepwise amino acid fitting to
the density map if no model is present and atomic
resolution data is available. Once the structure is solved,
it can then be deposited to the Protein Data Bank, an
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online database that contains biological structures that
have been solved to date (Figure 5f).

DISCUSSION AND FUTURE DIRECTION
As shown in Figure 4, a substantial amount of lpg2149
was successfully produced following this optimized
protocol. With this optimized protocol and lpg2149
construct identified, we wanted to see how lpg2149
inhibits MavC and MvcA by obtaining a crystal structure.
However, this was solved by another group before we
obtained our structure (Wang et al., 2020). One of the
future directions of this project is to study the mechanism
of inhibition between lpg2149 and MavC. An inhibition
assay, which involves the ubiquitination of UbE2N with
the aid of MavC in the presence of differing concentrations of lpg2149, can be used to observe the extent of
wild-type lpg2149 inhibition on MavC (Figure 6a). As
shown in the inhibition assay, with increasing amounts of
lpg2149 a reduced amount of UbE2N-Ub is observed.
These inhibition assays can be used to analyze key

FIGURE 5. Crystallization and X-ray diffraction. Crystal screening is conducted to obtain a crystal (a–b). The crystal’s
structure is analyzed and solved using X-ray diffraction and online programs (c–f).

FIGURE 6. Inhibition assays and residue sites. The results of an inhibition assay with an increasing concentration of
lpg2149 are shown in the electrophoresis gel (a). Lpg2149 is shown with residue sites highlighted in violet that could be
potentially mutated to test their importance in the binding of lpg2149 with MavC (b).

residues of lpg2149 by performing the assay with mutants
of lpg2149. If specific residues of lpg2149 were mutated
and then tested with the inhibition assay, the effects of
these mutations in inhibiting MavC can be compared to
those of wild-type lpg2149. If the ubiquitination of

UbE2N is impaired, it can be deduced that the specific
mutation of lpg2149 is of low importance, since lpg2149
is still inhibiting MavC despite the mutation and vice
versa. Additionally, the assay would test different concentrations of lpg2149 with each mutation to see how the
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concentration of mutated lpg2149 affected the reactions.
The different concentrations of lpg2149 were 0μM,
0.1μM, 0.25μM, 0.5μM, 1μM, 2μM and 5μM. As a future
direction, mutants that are presented on the MavC
interface with lpg2149 (highlighted in violet, Figure 6b)
can be the first ones to be tested as residues that may play
an important role in the binding of lpg2149 to MavC.
Additionally, biolayer interferometry can be used to study
the binding affinity by measuring the ratio of association
to dissociation of lpg2149 with its binding partner. These
analysis methods studying the interactions of lpg2149
with other L. pneumophila effectors would be beneficial
in improving our understanding of lpg2149 function and
L. pneumophila pathogenesis.
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